Sep 09, 2021 / 06:45PM GMT
Catherine Walden Ramsey Schulte - Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
All right. Hello, everyone. Thank you for joining. I'm Catherine Schulte, I cover Life Sciences and Diagnostics here at Baird. We're very excited to have NanoString here with us today, and representing the company, we have Brad Gray, President and CEO.
Before we begin, just a reminder to refer to Baird's website and our published research for important disclosures about topics that we'll be discussing today. So we're just going to jump right into Q&A. If anyone from the audience has any questions, you can submit them via the portal, and we will come into the conversation. So with that, Brad, thanks so much for joining us today.
R. Bradley Gray - NanoString Technologies, Inc. - CEO, President & Director
Great to be here, Catherine. Thanks for having us.
NanoString Technologies Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers